» Articles » PMID: 30402448

Increased CCR7PD-1CXCR5CD4 T Cells in Peripheral Blood Mononuclear Cells Are Correlated with Immune Activation in Patients with Chronic HBV Infection

Overview
Specialty Gastroenterology
Date 2018 Nov 8
PMID 30402448
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

T follicular helper cells (Tfh cells) affect essential immune pathogenesis in chronic hepatitis B virus (HBV) infection. The CCR7PD-1 Tfh subset has a partial Tfh effector phenotype and is associated with active Tfh differentiation, whereas the CCR7PD-1 Tfh subset is a resting phenotype. We recruited 20 healthy volunteers and 77 patients with chronic HBV infection, including those in the immune tolerant (IT) phase (n=19), immune clearance (IC) phase (n=20), low replicative (LR) phase (n=18), and reactivation (RA) phase (n=20). The expression of CD4, CXCR5, PD-1, and CCR7 was detected in T cells from peripheral blood by flow cytometry. The frequency of the CCR7PD-1 T subset was significantly higher in the patients than in the healthy controls (14.92±4.87% vs 12.23±2.95%, p=0.018). The frequency of this Tfh subset in the IC group (18.42%±3.08) was increased compared with the IT group (11.94±2.87%, p=0.001) and LR group (13.65±4.93%, p=0.031) and was higher in the RA group than in the IT group (16.03±5.37% vs 11.94±2.87%, p=0.030). We observed a weak positive correlation between the CCR7PD-1 Tfh subset population and the alanine transaminase (ALT) level (r=0.370, p=0.001). The CCR7PD-1 Tfh subset in the chronic HBV-infected patients was elevated to various degrees among the different immune phases. CCR7PD-1CXCR5CD4 T cells are correlated with the immune status of chronic HBV infection patients and may be developed as a potential indicator for antiviral treatment.

Citing Articles

Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity.

Zheng P, Dou Y, Wang Q Front Cell Infect Microbiol. 2023; 13:1206720.

PMID: 37424786 PMC: 10324618. DOI: 10.3389/fcimb.2023.1206720.


Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation.

Dumolard L, Aspord C, Marche P, Macek Jilkova Z Front Immunol. 2023; 14:1148111.

PMID: 37056774 PMC: 10086248. DOI: 10.3389/fimmu.2023.1148111.


Novel Molecular Therapeutics Targeting Signaling Pathway to Control Hepatitis B Viral Infection.

Yan Y, Qiu Y, Davgadorj C, Zheng C Front Cell Infect Microbiol. 2022; 12:847539.

PMID: 35252042 PMC: 8894711. DOI: 10.3389/fcimb.2022.847539.


CD4 T Cells in Chronic Hepatitis B and T Cell-Directed Immunotherapy.

Buschow S, Jansen D Cells. 2021; 10(5).

PMID: 34066322 PMC: 8148211. DOI: 10.3390/cells10051114.


Frontiers of Autoantibodies in Autoimmune Disorders: Crosstalk Between Tfh/Tfr and Regulatory B Cells.

Ding T, Su R, Wu R, Xue H, Wang Y, Su R Front Immunol. 2021; 12:641013.

PMID: 33841422 PMC: 8033031. DOI: 10.3389/fimmu.2021.641013.


References
1.
Ma C, Phan T . Here, there and everywhere: T follicular helper cells on the move. Immunology. 2017; 152(3):382-387. PMC: 5629422. DOI: 10.1111/imm.12793. View

2.
Zhong H, Xibing G, Yaping D, Zheng W, Decai F, Xiaoye G . Interleukin-7 in Patients With Chronic Hepatitis B May Have Effect on T Follicular Helper Cells and Specific Cellular Immunity. Hepat Mon. 2016; 16(9):e36068. PMC: 5091030. DOI: 10.5812/hepatmon.36068. View

3.
Tangye S, Ma C, Brink R, Deenick E . The good, the bad and the ugly - TFH cells in human health and disease. Nat Rev Immunol. 2013; 13(6):412-26. DOI: 10.1038/nri3447. View

4.
Kubo S, Nakayamada S, Yoshikawa M, Miyazaki Y, Sakata K, Nakano K . Peripheral Immunophenotyping Identifies Three Subgroups Based on T Cell Heterogeneity in Lupus Patients. Arthritis Rheumatol. 2017; 69(10):2029-2037. DOI: 10.1002/art.40180. View

5.
Tangye S . Advances in IL-21 biology - enhancing our understanding of human disease. Curr Opin Immunol. 2015; 34:107-15. DOI: 10.1016/j.coi.2015.02.010. View